A man, 51, had to go to hospital in Hong Kong after he scratched his eye while taking off his face mask during his lunch break at work. He scraped his eye after flipping the mask while pulling it off.
Share
In another image, a beaming Athena, dressed in a light blue jumper, poses with a white dog, thought to be the family s pet.
Athena is tenth in the line of succession to the Danish throne. She is the daughter of Prince Joachim, 51, and Princess Marie of Denmark, 44.
The young royal (pictured) sported a beaming smile when enjoying a frolic in the snow in Paris, where she lives with her parents Prince Joachim and Princess Marie, and her 12-year-old brother Prince Henrik
In two of the four photographs shared, the princess made sure to wrap up warm against the chilly weather by donning a light puffer coat and adorable pink earmuffs (pictured)
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Amicus Therapeutics Announces Presentations and Posters at the 17th Annual WORLDSymposium™ 2021
Amicus Therapeutics, Inc.January 21, 2021 GMT
CRANBURY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on discovering, developing and delivering novel medicines for rare diseases, today announced that three oral presentations and ten posters highlighting its development programs for Lysosomal Disorders will be included at the 17th Annual WORLD
Symposium ™ 2021, to be held virtually February 8-12, 2021.
ADVERTISEMENT
Oral Platform Presentations:
Direct intercellular cross-correction of α-galactosidase-A deficiency in Fabry disease podocytes through tunneling nanotubes in a mixed cell culture model – Behzad Najafian, MD, Department of Pathology, University of Washington, Seattle, WA, USA (Monday, F
Date Time
Personalized vaccine produces long-lasting anti-tumor response in patients with melanoma, study shows
Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women’s Hospital, and the Broad Institute of MIT and Harvard report in a new study.
The findings, published online today by the journal Nature Medicine, demonstrate the staying power of the immune response generated by the vaccine, known as NeoVax, which works by targeting specific proteins on each patient’s tumor cells. The researchers found that, nearly four years after vaccination, the patients’ immune system cells were active not only against tumor cells with those distinctive proteins, but also spread to other proteins found in those patients’ tumor cells.
E-Mail
BOSTON - Four years after patients with melanoma were treated with a personalized cancer vaccine, the immune response kindled by the vaccine remains robust and effective in keeping cancer cells under control, researchers at Dana-Farber Cancer Institute, Brigham and Women s Hospital, and the Broad Institute of MIT and Harvard report in a new study.
The findings, published online today by the journal
Nature Medicine, demonstrate the staying power of the immune response generated by the vaccine, known as NeoVax, which works by targeting specific proteins on each patient s tumor cells. The researchers found that, nearly four years after vaccination, the patients immune system cells were active not only against tumor cells with those distinctive proteins, but also spread to other proteins found in those patients tumor cells.